Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
1
13%
Ph phase_1
6
75%
Ph phase_3
1
13%

Phase Distribution

6

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
6(75.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(7)
Completed(1)

Detailed Status

Recruiting4
Not yet recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (75.0%)
Phase 21 (12.5%)
Phase 31 (12.5%)

Trials by Status

completed113%
not_yet_recruiting338%
recruiting450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8